Risk Modeling for District Prioritization in Pakistan Laina Mercer Steve Kroiss, Hil Lyons, Guillaume Chabot-Couture 20 April, 2016.

Slides:



Advertisements
Similar presentations
Polio Communication Indicators Reflections from Polio Communication TAG/Review Process.
Advertisements

1 Measles in Fraser Health Michelle Murti, MHO Fraser Health Authority, BC CPHA May 27, 2014.
1 Dr. Azhar Abid Raza Washington Sept 2011 Measles elimination in Pakistan.
District 7630 Rotary International PolioPlus. The status of polio in 1988 Over 350,000 cases of polio reported Rotarians raise $247 million for PolioPlus,
Rotary Foundation Seminar Polio Eradication. From left Canadian PM Stephen Harper, Nigerian President Goodluck Jonathan, Australian PM Julia Gillard PM.
Poliomyelitis Surveillance in Ireland 4 th April, 2014.
IPV IPV Rapidly produces high level of protective antibodies No risk of vaccine associated illness No interference from other enteroviruses. I.P.V. produces.
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
Donor Meeting: Health Update 14 th June, Health Sector Response Total Beneficiaries – estimated 25 Million Total Funds Used – US$ 156 Million Activities:
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
WHO RAP Team: Perspective and Update WORKSHOP ON ANALYZING THE POLIO ERADICATION ENDGAME, Seattle, 1-2 July 2015.
Infectious Disease Epidemiology Sharyn Orton, Ph.D. American Red Cross, Rockville, MD Suggested reading: Modern Infectious Disease Epidemiology (1994)
The Reaching Every District (RED) strategy.  Re-establish outreach services  Conduct supportive supervision  Establish community links with service.
Criteria for Assessment of Performance of Cancer Risk Prediction Models: Overview Ruth Pfeiffer Cancer Risk Prediction Workshop, May 21, 2004 Division.
Polio Update Pre Tender Meeting 11 th December 2008 UNICEF Supply Division.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
1. Infection Control Risk Assessment Terrie B. Lee, RN, MS, MPH, CIC Director, Infection Prevention & Employee Health Charleston Area Medical Center Charleston,
1 | Global Immunization Meeting: PIA Sitges, June 2015 New tools and strategies for maternal and neonatal tetanus and measles/rubella elimination.
Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.
Data in WHO HQ as of 09 October 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this.
1 Progress Towards Polio Eradication in EMR. 2 Status of global eradication Priority countries (except EMR) : Intensification : Certification,
Epidemiology of Vaccine Preventable diseases in Iran
Current Status of Immunization Service Delivery in Africa Mary Harvey AFR/SD/HRD SOTA/PHN Meeting June 13, 2002.
Progress of Polio Eradication in India, Current Risks & Actions taken on last IEAG report 24 th IEAG, New Delhi 15 March 2012 Dr. Ajay Khera Deputy Commissioner.
Deliberations of the 23 rd IEAG July 2011.
JAHSR TECHNICAL REVIEW MEETING EPI Report Dr Dafrossa C Lyimo Programme Manager 7th September 2010 Dar es salaam.
Polio Eradication Initiative Pakistan Meeting of the Independent Monitoring Board for GPEI; 7 th May 2013.
Measles elimination Dr. As’ad Ramlawi Palestine..
Governments of the World Present Status Leadership & Commitments New Funding Opportunities.
Sustaining Polio Eradication IEAG March 2012 The experience of polio-free countries with importations of WPV: Implications for India.
Afghanistan Polio Eradication Initiative Surveillance Update Week 18 ( Ending on Saturday 9 May 2009 ) National Surveillance Office May 12, 2009.
PolioPlus: Keep our Promise to Eradicate Polio PolioPlus: Keep our Promise to Eradicate Polio.
Polio Endgame Strategy in India Considerations and Way Forward WHO-India, NPSP 15 March 2012.
1 Polio Strategic Plan India Expert Advisory Group July 2011 Impact & prospects at the half-way point.
Risk assessment for VTE Dr Roopen Arya King’s College Hospital.
Eradication of Poliomyelitis Global & National Overview Goal : Complete interruption of wild poliovirus transmission Dr OR Goldie (State EPI Officer Punjab)
Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Supplementary Immunization Activities Quality, Coverage of high risk populations/ areas, proposed plans for IEAG Meeting 15 March 2011.
BMTRY 763. Space-time (ST) Modeling (BDM13, ch 12) Some notation Assume counts within fixed spatial and temporal periods: map evolutions Both space and.
1 Optimal Eradication of Poliomyelitis Ryan Hernandez May 1, 2003.
Sudan EPI Benefits From Polio Eradication Program M&RI Annual Partners Meetings Washington D.C September 2015 Sudan EPI Benefits From Polio Eradication.
Afghanistan Polio Eradication Initiative Surveillance Update Week 15 ( Ending on Saturday 18 April 2009 ) National Surveillance Office April 21, 2009.
Poliovirus Surveillance and Risks to Polio Eradication in India Dr. Hamid Jafari WHO-NPSP.
ASSESSMENT OF THE ANNUAL VARIATION OF MALARIA AND THE CLIMATE EFFECT BASED ON KAHNOOJ DATA BETWEEN 1994 AND 2001 Conclusions 1. One month lag between predictors.
Poliovirus Surveillance status of quality, actions to improve sensitivity WHO-India 15 March 2012.
Afghanistan Polio Eradication Initiative Surveillance Update Week 13 ( Ending on Saturday 4 April 2009 ) National Surveillance Office April 07, 2009.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
Measles and Rubella Initiative Financial Resource Requirements for Measles and Rubella Annual Partners Meeting, September
The polio endgame and silent circulation: some related research.
Approaches to modeling, parameter estimation, and policy guidance during the endgame Guillaume Chabot-Couture Philip Eckhoff Mike Famulare Hao Hu Hil Lyons.
PROGRESS TOWARDS MEASLES & RUBELLA ELIMINATION EXPERIENCE FROM OMAN SALAH AL AWAIDY, MD COMMUNICABLE DISEASES ADVISOR MOH, OMAN
Integrated disease surveillance and care delivery: stories from polio (and weather) Mike Famulare.
END POLIO FOREVER NOW 3,145 เสียชีวิต 21,269 ทุพพลภาพ.
Data quality for polio eradication: Accuracy & reliability
Polio Plus Polio Eradication Initiative
Targeted supplementary immunization
Perspective and Update
Risk Mapper tool workshop
Performance of AFP surveillance, 2014
The Role of Supplementary Immunization Activity Scheduling on Measles Incidence in Nigeria Kurt Frey April 20, 2017 IDM Disease Modeling Symposium Measles.
AMINU M,1 AHMAD A A1 and OGUNRINDE G O2
POLIOPLUS FACT SHEET Feb 2018
Epidemiological Update on Public Health Emergencies
Polio Eradication in Uttarakhand
15/01/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
Maintaining Elimination in an Environment of Persistent Importation
Risk mapping Embedded tool for disease outbreak prevention
Polio Eradication Progress & Challenges.
Presentation transcript:

Risk Modeling for District Prioritization in Pakistan Laina Mercer Steve Kroiss, Hil Lyons, Guillaume Chabot-Couture 20 April, 2016

Recent History WPV1 cases in 2016: – Afghanistan: 4 cases in 3 districts – Pakistan: 8 cases in 8 districts Last 6 months represent the lowest high season since 2007 in Pakistan. Where and how should the program intervene?

We Want a Framework for Prioritizing Sub-National Areas Why? The Pakistan polio program plans their vaccination campaigns annually They need to decide how and where to allocate resources and target special interventions

We Want a Framework for Prioritizing Sub-National Areas Why? The Pakistan polio program plans their vaccination campaigns annually They need to decide how to allocate resources and where to target special interventions What information do we have to study risk in space and time? The most geographically and temporally rich data is the Acute Flaccid Paralysis (AFP) surveillance data In addition to providing information about WPV1 cases, the non-polio AFP cases provide us with routine and campaign dose histories from a sample from the population

A Framework for Prioritizing Districts Based on Risk Estimate a risk score based on both the probability of a case and the number of cases over 6 months in each district Risk is modeled as a function of – Zero dose routine immunization (RI) fraction – Under immunized fraction – Vaccine derived type 1 population immunity – Recent WPV1 cases – High season (Jan-June vs. July-Dec)

Dose History Data Is Noisy

Space-time Smoothing Model for Covariates

Impact of Smoothing Covariates – Independent Interaction

Impact of Smoothing Covariates – Structured Interaction

Smoothed Zero Dose RI and Under Immunized Rate

Vaccine Derived Type 1 Immunity Calculations Annual age-specific campaign quality is estimated with a Bayesian spatiotemporal model [3] Population Immunity projected based on campaign type and quality. [3] Upfill-Brown, Voorman, Chabot-Couture, Shuaib, Lyons (2016) Peshawar

Poisson Hurdle Model

Final Model The probability of having at least one case in a 6 month period Type 1 immunity - negatively associated Under immunized fraction - positively associated Zero dose RI – positively associated Recent cases – positively associated High Season The number of cases expected given at least one case Type 1 immunity – negatively associated High Season

Model Validation Very good predictive accuracy at the district level as measured by area under the curve. Approximately 80% sensitivity for top 50 ranked districts over time.

Impact and Future Directions Pakistan polio program uses these results to help inform their tiered district prioritizations. Helps to inform on the number and location of sub-national vaccination campaigns. Work is ongoing for the 2016 classifications. Considering risk analysis for sub- district geographies.

Acknowledgements IDM Polio Team Steve Kroiss Hil Lyons Mike Famulare Kevin McCarthy Guillaume Chabot-Couture Alex Upfill-Brown National Emergency Operating Center – Islamabad, Pakistan Jamal Ahmed Abdirahman Mahamud Ashraf Wahdan And many others The Gates Foundation Arie Voorman Sue Gerber Sidney Brown And many others

References 1.Knorr-Held, Leonhard. "Bayesian modelling of inseparable space-time variation in disease risk." Statistics in medicine (2000): Schrödle, Birgit, and Leonhard Held. "Spatio‐temporal disease mapping using INLA." Environmetrics 22.6 (2011): Upfill-Brown Alexander, Voorman Arend, Chabot-Couture Guillaume, Shuaib Faisal, Lyons Hil. “Analysis of vaccination campaign effectiveness and population immunity to support and sustain polio elimination in Nigeria.” To appear in BMC Medicine. (2016)

Additional Slides

Impact of Smoothing Covariates – No Interaction

Observed Cases and Smoothed Risk

Residual Risk

Sensitivity of List Sensitivity of list (T1- T3) generally near 80%. Poor predictive performance during outbreaks in Punjab province in 2008 and 2009.

District Prioritization Framework Tier 1: Reservoir Districts (10-15) – These area the areas that must be fixed if the program is to succeed. – Targeted with national and sub-national vaccination campaigns. Tier 2: High Risk/Vulnerability Districts (15-30) – NIDs + SNIDs – These area areas that are frequent recipients of virus and have known quality & immunity problems – These areas may harbor virus even if eliminated from reservoirs and subsequently re-infect them – Targeted with national and sub-national vaccination campaigns. Tier 3: Outbreak Districts (Flexible) – NIDs + SNIDs, with SNIDs for 6 months following case/isolate – Areas not at high risk to report a case or become problematic – Areas to be added to the sub-national vaccination calendar for a few rounds Tier 4: Rest of Pakistan – Areas where RI is strong, quality is known to be high and/or risk is known to be low. – Will be included in national vaccination campaigns.

Final Classification in Collaboration with Pakistani Program Approximately 80% sensitivity for T1-T3 districts. Process in ongoing for planning the campaign calendar.

Final Classification